Alternative Treatments for Bipolar Disorder

Several alternative and complementary approaches show genuine promise for managing bipolar disorder, particularly the depressive side of the condition, though none has enough evidence to replace standard mood stabilizers or psychiatric care. The most studied options include omega-3 fatty acids, N-acetylcysteine, bright light therapy, and transcranial direct current stimulation. Each has at least some randomized trial data behind it, and the effects tend to be moderate rather than dramatic. The real story is more nuanced than “natural equals safe” or “alternative equals unproven,” and the distinction between what helps bipolar depression and what might accidentally trigger mania is critical to understand.

Omega-3 Fatty Acids

Fish oil is probably the most widely discussed supplement for bipolar disorder, and the evidence for it is mixed but leans positive for one specific phase: bipolar depression. A meta-analysis pooling data from five trials found a moderate effect favoring omega-3 over placebo for depressive symptoms, concluding that the evidence was strong enough to consider omega-3 as an add-on treatment.¹ A broader meta-analysis of omega-3 in depressive disorders also found a positive effect in the bipolar subgroup, though the authors cautioned that the evidence was weakened by having to exclude several studies from the quantitative analysis.²

The practical takeaway is that omega-3 supplements, particularly those high in EPA, appear to help with the depressive pole of bipolar disorder when added to existing medication. They do not appear to help much with mania, and they are not a replacement for mood stabilizers. For someone already on medication who still struggles with depressive episodes, omega-3 is one of the better-supported add-on options available.

N-Acetylcysteine

N-acetylcysteine, usually called NAC, is an inexpensive amino acid derivative best known as the antidote for acetaminophen overdose. It works as a precursor to glutathione, a major antioxidant in the brain, and researchers became interested in it for bipolar disorder partly because both depression and bipolar disorder are linked to glutathione depletion.³

A meta-analysis of six randomized controlled trials found that adding NAC to standard bipolar treatment produced a moderate benefit for depressive symptoms compared to placebo, though the confidence interval was wide, meaning the true effect could be anywhere from small to fairly large.⁴ A maintenance trial examined what happened after an initial open-label phase, looking at whether staying on NAC could keep improvements going over time.⁵ The results were encouraging enough to keep NAC on the radar of clinical researchers, though there is still meaningful uncertainty about exactly how large the benefit is.

NAC is generally well tolerated, which is a significant advantage. The typical dose studied in trials ranges from about 1,000 to 2,000 mg per day. As with omega-3, its role is as an add-on, not a standalone treatment.

Coenzyme Q10 and Mitochondrial Approaches

A separate line of research focuses on mitochondrial function, the energy-producing machinery inside cells. There is growing evidence that mitochondrial dysfunction plays a role in bipolar disorder, and several supplements target this pathway. The most studied is coenzyme Q10 (CoQ10). A double-blind controlled trial found that adding CoQ10 to standard medication improved depression symptoms after eight weeks compared to placebo, with more people in the CoQ10 group meeting the threshold for clinical response. The supplement was well tolerated and had minimal side effects.⁶ A smaller study in older adults with bipolar depression also found that CoQ10 reduced depression severity over a few weeks.⁷

A larger trial tested a combination of mitochondrial-supporting agents including NAC against placebo over 16 weeks and found no difference during the treatment phase itself. But something unexpected happened: at the follow-up visit four weeks after people stopped treatment, those who had been in the active group showed greater improvement on depression, functioning, and overall clinical impression compared to placebo.⁸ That delayed effect is hard to explain, and the researchers themselves noted it warrants further study. It may suggest that mitochondrial interventions work on a slower timescale than conventional treatments, or it may be a statistical artifact in a modest-sized trial.

Bright Light Therapy

Bright light therapy, the same approach used for seasonal affective disorder, has been tested specifically for bipolar depression with genuinely encouraging results. A meta-analysis of seven randomized trials found that light therapy produced significant improvement in depression scores compared to control conditions, with more than twice the odds of clinical response.⁹ Another meta-analysis similarly found decreased depression severity after bright light therapy in bipolar patients.¹⁰

One particularly notable trial found response rates of about 78% in the light therapy group compared to roughly 43% in controls, with the median time to onset of benefit being just over four days. No participants in that study developed hypomania, a key safety concern with any antidepressant-type intervention in bipolar disorder.¹¹ That speed of onset is faster than most medications and faster than the supplements discussed above, which makes light therapy an appealing option for people in acute depressive episodes.

One practical consideration: the timing of light exposure matters. Some clinicians recommend midday rather than early morning sessions for people with bipolar disorder, based on the theory that morning bright light might be more likely to trigger hypomania. The evidence on optimal timing is still evolving, and this is a conversation to have with a treatment provider before buying a light box.

Blue Light Blocking for Mania

A related but distinct approach targets the manic side of bipolar disorder by blocking blue light in the evening, typically with amber-tinted glasses. The idea is that reducing blue light exposure helps stabilize circadian rhythms and may calm the overactivation seen in mania. Early clinical studies generated excitement about this concept.¹²

However, a recent randomized controlled trial poured cold water on these initial hopes. The study randomized 42 patients experiencing mania to either blue-blocking glasses or lightly tinted control glasses and found no significant difference in mania scores between the groups.¹³ This is a good reminder that early enthusiasm about any intervention often deflates when larger, better-designed trials come along. Blue-blocking glasses are unlikely to hurt, but claims that they treat mania appear overblown based on the current best evidence.

Transcranial Direct Current Stimulation

Transcranial direct current stimulation, or tDCS, sends a weak electrical current through the scalp to alter brain activity. It is non-invasive, uses battery-powered devices, and has been explored for many psychiatric conditions. For bipolar depression specifically, the evidence is genuinely promising. A systematic review covering over 200 bipolar depression patients across multiple studies found consistent reductions in depression scores after tDCS treatment, with improvements ranging from about 18% to 92% depending on the study. Side effects were mild and temporary.¹⁴

The most rigorous trial on this, a randomized sham-controlled study, found that active tDCS produced significantly better improvement than sham stimulation. Roughly two-thirds of people in the active group responded to treatment, compared to about 30% with sham. Remission rates were higher in the active group but did not reach statistical significance.¹⁵ Home-based versions of tDCS are also being studied, with an open-label trial finding improvements in quality of life linked to reductions in depressive symptoms, though controlled trials are still needed to confirm this.¹⁶

Low-Field Magnetic Stimulation

A different type of brain stimulation uses low-intensity pulsating electromagnetic fields. An early study found that bipolar patients who received this type of stimulation during an MRI-based procedure reported mood improvement at much higher rates than those who received a sham procedure.¹⁷ A follow-up study confirmed rapid mood improvements after low-field magnetic stimulation in both bipolar and unipolar depression, with significant effects on positive affect measures.¹⁸ More recent real-world data from clinical settings have shown that transcranial pulsating electromagnetic fields reduced depressive symptoms in patients with both unipolar and bipolar depression.¹⁹

This area is still relatively early in its development, and the trials so far have been small. The speed of the effect is what makes it interesting; some participants reported mood changes within a single session, which is unusual for any depression treatment. Whether this translates into sustained benefits with repeated use is still being studied.

Melatonin and Sleep Stabilization

Sleep disruption is both a symptom and a trigger in bipolar disorder. When sleep falls apart, mood episodes often follow. This makes sleep-focused interventions particularly logical as a complementary strategy. Melatonin has attracted attention because circadian rhythm disturbances are a core feature of the condition.²⁰

Researchers have argued that melatonin and melatonin-targeting drugs could serve as useful add-on treatments alongside mood stabilizers, particularly for addressing insomnia and delayed sleep timing that often precede mood episodes.²¹ A study of bipolar patients who also had delayed sleep-wake phase disorder found that personalized melatonin treatment shifted sleep onset earlier by about 45 minutes, improved sleep efficiency, and increased total sleep time.²² While that may sound modest, in bipolar disorder, regularizing sleep timing can have outsized effects on mood stability. The emphasis here is less on melatonin as a direct mood treatment and more on its role in preventing the sleep disruptions that cascade into mood episodes.

Mindfulness-Based Cognitive Therapy

Mindfulness-based cognitive therapy, known as MBCT, combines meditation practices with cognitive behavioral techniques and has been studied specifically in bipolar populations. An open pilot trial found that participants reported improvements in executive functioning, memory, and their ability to initiate tasks after completing the program. These cognitive gains were linked to increases in mindful awareness rather than simply to improvements in depression.²³ However, some of these improvements faded after the program ended, though benefits to executive functioning persisted at three months.

A randomized controlled trial gave a more sobering picture of MBCT’s effect on mood episodes themselves: it did not significantly reduce the time to depressive or manic relapse, the total number of episodes, or mood severity at 12-month follow-up. There was, however, some evidence that MBCT reduced anxiety symptoms that commonly accompany bipolar disorder.²⁴ A separate follow-up survey found that patients who maintained regular informal mindfulness practice reported persistent changes in their daily lives, and those who practiced mindful breathing had fewer depressive relapses.²⁵

So MBCT probably will not prevent mood episodes by itself, but it may help with anxiety, cognitive difficulties, and quality of life. For someone already stabilized on medication who struggles with the cognitive fog and anxiety that often linger between episodes, that is a meaningful contribution.

Exercise

Aerobic exercise has solid evidence for improving functioning, cognition, and depressive symptoms across serious mental illnesses.²⁶ For bipolar disorder specifically, researchers have highlighted exercise’s potential to address one of the condition’s most persistent and undertreated features: neurocognitive dysfunction. The proposed mechanisms involve effects on brain cell growth, inflammation, insulin sensitivity, and neurotransmitter systems, all of which are implicated in the cognitive problems seen in bipolar disorder.²⁷

The challenge is practical rather than scientific. During depressive episodes, the motivation to exercise is often at its lowest, and during mania, exercise can become excessive and destabilizing. Building a regular exercise routine during stable periods, with reasonable goals and some accountability structure, is the approach most likely to carry benefits into vulnerable periods.

Probiotics and Gut Health

The gut-brain axis has become a hot topic across psychiatry, and bipolar disorder is no exception. A systematic review found that people with bipolar disorder show differences in their gut microbiome composition, and that probiotic supplementation lowered rehospitalization rates while improving depressive symptoms and cognitive function.²⁸ Another systematic review found preliminary support for probiotics improving bipolar symptoms, with some suggestion of benefit for manic symptoms as well.²⁹

This is still early-stage research. The studies are small, the probiotic strains and doses vary widely between trials, and it is unclear which specific bacteria matter most. But the rehospitalization finding is interesting from a practical standpoint, because even modest reductions in hospitalizations represent a meaningful improvement in someone’s life.

Ketogenic and Metabolic Diets

The ketogenic diet, a very low-carbohydrate regimen originally developed for epilepsy, has generated considerable interest as a potential bipolar treatment based on shared neurobiological pathways between epilepsy and mood disorders. Early case reports described two women with bipolar II disorder who maintained ketosis for up to three years and achieved mood stabilization comparable to what they had experienced with medication, without adverse effects.³⁰ A pilot trial protocol has been designed to test a “ketogenic-mimicking diet” using ketone ester supplements combined with a low-glycemic dietary approach, which would be easier to sustain than strict ketosis.³¹

The ketogenic approach is intriguing but should be approached with caution. Strict ketogenic diets are difficult to maintain, can interact with psychiatric medications, and extreme dietary changes during mood episodes are potentially destabilizing. Case reports and pilot protocols are the weakest forms of clinical evidence. Anyone considering this should do so under close medical supervision, not from internet inspiration alone.

What Can Trigger Mania

The most important safety consideration with alternative treatments for bipolar disorder is the risk of triggering mania or hypomania. This risk is not theoretical. A case report described a patient who developed mania with psychotic features while using S-adenosyl-L-methionine (SAMe) alongside an SSRI antidepressant.³² SAMe and St. John’s wort both have the potential to induce mania in people with bipolar disorder.³³ A case report also documented hypomania developing in a patient using more than 25 herbal supplements simultaneously along with cannabis, with ginseng identified as a likely contributor.³⁴

The supplements most commonly flagged for mania risk include:

SAMe: Acts as a methyl donor in neurotransmitter synthesis and can push mood upward unpredictably, particularly in combination with antidepressants.
St. John’s wort: Functions like a mild antidepressant and carries the same mania risk as pharmaceutical antidepressants for people with bipolar disorder.
Ginseng: Has stimulant-like properties that may destabilize mood in vulnerable individuals.

The pattern here is that anything with antidepressant-like properties carries a nonzero risk of flipping someone into mania. This applies to herbal products just as much as it applies to prescription antidepressants. People with bipolar disorder should be especially skeptical of supplements marketed for “mood support” or “energy” without checking whether those products have been studied in bipolar populations specifically.

Why People Seek Alternatives and What the Research Says About That

A study of veterans with bipolar disorder found that those who turned to complementary approaches, whether herbal therapies or practices like meditation, tended to be people who felt their standard medications were not effectively relieving their manic or depressive symptoms or helping with social and work functioning. However, using these alternatives was not associated with reduced medication compliance.³⁵ A study from Argentina and Colombia similarly found that complementary medicine use did not change people’s adherence to or satisfaction with their psychiatric treatment.³⁶

This is reassuring, because the biggest fear clinicians have about alternative treatments is that they will replace proven therapies. The data suggest that most people use them alongside their medications, not instead of them. The danger lies less in the population average and more in individual cases where someone decides a supplement or diet is “working” and stops their mood stabilizer. That scenario is where the real harm happens, and it is worth stating plainly: the alternative treatments with the best evidence are all studied as add-ons to existing medication, not as replacements.

Ashwagandha and Other Herbal Options

Ashwagandha (Withania somnifera) has been studied for cognitive dysfunction across a range of psychiatric conditions including bipolar disorder. A systematic review found that it generally improved performance on cognitive tasks, executive function, attention, and reaction time, and was well tolerated with minimal side effects.³⁷ The caveat is that the populations studied were quite varied, including older adults with cognitive impairment and people with schizophrenia or bipolar disorder, making it hard to draw firm conclusions about any single condition. Ashwagandha has adaptogenic properties and is generally considered safe, but as with any supplement, its effects in bipolar disorder specifically have not been studied in large controlled trials.

The broader herbal landscape for bipolar disorder is thin on rigorous evidence. Many herbal products are marketed to people with mood disorders, but very few have been tested in bipolar populations specifically. The gap between “this herb helps with stress in healthy people” and “this herb is safe and effective for someone on lithium” is enormous, and most herbal products have not crossed it.

How to Think About All of This

The alternative treatments with the strongest evidence for bipolar depression, in rough order of how much controlled trial data supports them, are bright light therapy, tDCS, omega-3 fatty acids, and NAC. Each has meta-analytic or randomized trial evidence showing moderate benefits when added to standard medication. Melatonin, exercise, and CoQ10 have smaller evidence bases but plausible mechanisms and favorable safety profiles. Probiotics and ketogenic diets are in early research phases. Mindfulness-based approaches help more with anxiety and cognitive complaints than with core mood episodes.

For mania specifically, the evidence landscape is much thinner. Blue-blocking glasses have not held up to rigorous testing. Low-field magnetic stimulation shows rapid mood effects in preliminary work but has not been tested for sustained anti-manic properties. The most important mania-related guidance is avoidance: staying away from supplements like SAMe and St. John’s wort that can trigger manic episodes. Sleep regularity, supported by melatonin when appropriate, is probably the most actionable protective strategy against mania that falls outside conventional pharmacology.